Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.

OBJECTIVE To identify the cells that produce BAFF in the salivary glands of patients with primary Sjögren's syndrome (SS), and to analyze BAFF receptor expression by local T and B lymphocytes. METHODS We used 3 methods to identify the source of BAFF: in situ hybridization of the transcripts for BAFF combined with staining of membrane markers, regular and real-time reverse transcription-polymerase chain reaction (RT-PCR) of cultured epithelial cells, and RT-PCR of sorted single-cell T and B lymphocytes eluted from salivary glands. Cells expressing TACI, BCMA, and B lymphocyte stimulator receptor 3 (BR-3) were disclosed by combining each specific staining of the receptors with each specific staining of the cells. The function of BAFF generated by epithelial cells on B lymphocytes was determined in short-term cocultures. RESULTS Transcripts for BAFF were seen in epithelial cells and infiltrating T lymphocytes and, for the first time, were detected in local B cells. It is interesting that BR-3 was present on these B cells but not on T cells. In contrast, TACI and, to a lesser degree, BCMA were observed on transitional B lymphocytes, whereas T lymphocytes were devoid of receptors for BAFF. Furthermore, this cytokine was shown to be functional, in that epithelial cell-bound BAFF extended the survival of normal B cells, but cell-free BAFF released in the supernatants did not. CONCLUSION These experiments establish that in primary SS, BAFF is produced not only by epithelial cells and T cells but also by B cells. The expression of receptors for BAFF would thus allow these receptors to participate in an autocrine pattern of self-stimulation.

[1]  J. Pers,et al.  A Conspicuous Role For B Cells In Sjögren’s Syndrome , 2007, Clinical reviews in allergy & immunology.

[2]  B. Cochener,et al.  Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). , 2007, Arthritis and rheumatism.

[3]  J. Pers,et al.  Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. , 2006, Arthritis and rheumatism.

[4]  J. Pers,et al.  Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? , 2005, Arthritis and rheumatism.

[5]  C. Ambrose,et al.  BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. , 2005, International immunology.

[6]  J. Pers,et al.  BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[7]  S. Hillion,et al.  Expression of RAGs in Peripheral B Cells outside Germinal Centers Is Associated with the Expression of CD51 , 2005, The Journal of Immunology.

[8]  R. Jonsson,et al.  Association Between Circulating Levels of the Novel TNF Family Members APRIL and BAFF and Lymphoid Organization in Primary Sjögren’s Syndrome , 2005, Journal of Clinical Immunology.

[9]  A. Rosenwald,et al.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.

[10]  T. Kipps,et al.  Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines1 , 2005, The Journal of Immunology.

[11]  J. Kutok,et al.  TNF Family Member B Cell-Activating Factor (BAFF) Receptor-Dependent and -Independent Roles for BAFF in B Cell Physiology1 , 2004, The Journal of Immunology.

[12]  C. Mackay,et al.  B Cell-Activating Factor Belonging to the TNF Family (BAFF)-R Is the Principal BAFF Receptor Facilitating BAFF Costimulation of Circulating T and B Cells1 , 2004, The Journal of Immunology.

[13]  T. Spector,et al.  The effect of moderate alcohol consumption on bone mineral density: a study of female twins , 2004, Annals of the rheumatic diseases.

[14]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[15]  X. Mariette,et al.  Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome , 2004, The Journal of pathology.

[16]  M. Scott,et al.  Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function , 2004, The Journal of Immunology.

[17]  F. Ajchenbaum‐Cymbalista,et al.  Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. , 2004, Blood.

[18]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[19]  M. Scott,et al.  Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells , 2003, The Journal of experimental medicine.

[20]  M. Cancro,et al.  Cutting Edge: B Cell Receptor Signals Regulate BLyS Receptor Levels in Mature B Cells and Their Immediate Progenitors 1 , 2003, The Journal of Immunology.

[21]  E. Clark,et al.  Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. , 2003, Blood.

[22]  R. Jonsson,et al.  Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome , 2003, Laboratory Investigation.

[23]  B. Nardelli,et al.  G-CSF–stimulated Neutrophils Are a Prominent Source of Functional BLyS , 2003, The Journal of experimental medicine.

[24]  R. Bram,et al.  Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. , 2002, Blood.

[25]  S. Pillemer,et al.  Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. , 2002, Arthritis and rheumatism.

[26]  P. Lipsky,et al.  Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome , 2002, Arthritis research.

[27]  P. Lipsky,et al.  Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. , 2002, Arthritis and rheumatism.

[28]  F. Mackay,et al.  BAFF: A fundamental survival factor for B cells , 2002, Nature Reviews Immunology.

[29]  D. Hilbert,et al.  Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators1 , 2002, The Journal of Immunology.

[30]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[31]  J. Kearney,et al.  Marginal-zone B cells , 2002, Nature Reviews Immunology.

[32]  H. Moutsopoulos,et al.  Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. , 2002, European journal of oral sciences.

[33]  J. Tschopp,et al.  Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen , 2001, The Journal of experimental medicine.

[34]  J. Tschopp,et al.  BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF , 2001, Science.

[35]  Paul A. Moore,et al.  Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS* , 2000, The Journal of Biological Chemistry.

[36]  M. Tourigny,et al.  Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response , 2000, The Journal of experimental medicine.

[37]  H. Shu,et al.  B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Moutsopoulos,et al.  Sjogren's Syndrome , 1999, Southern medical journal.

[39]  Amy S Orr,et al.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.

[40]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[41]  R. Bram,et al.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. , 1997, Science.

[42]  H. Moutsopoulos,et al.  Sjögren's syndrome: autoimmune epithelitis. , 1994, Bailliere's best practice & research. Clinical rheumatology.

[43]  J. D. Capra,et al.  Analysis of somatic mutation in five B cell subsets of human tonsil , 1994, The Journal of experimental medicine.

[44]  T. Daniels Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. , 1984, Arthritis and rheumatism.

[45]  H. Moutsopoulos,et al.  Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. , 1979, The American journal of medicine.

[46]  R. Akın,et al.  Sj??gren??s syndrome , 1975 .

[47]  J. Pers,et al.  A case for B cells in the pathogenesis of Sjögren's syndrome , 2007 .

[48]  E. S. St. Clair,et al.  New prospects for autoimmune disease therapy: B cells on deathwatch. , 2006, Arthritis and rheumatism.

[49]  J. Pers,et al.  BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome. , 2006, Arthritis and rheumatism.

[50]  J. Tschopp,et al.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. , 2002, The Journal of clinical investigation.

[51]  P. Moore,et al.  Synthesis and release of B-lymphocyte stimulator from myeloid cells. , 2001, Blood.